NCT06923774Recruiting
European Real-World Registry for Use of the Ion Endoluminal System
A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
The objective of this study is to collect collect real-world data for the Ion endoluminal system.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1200 (estimated)
- First submitted
- 4 Apr 2025
- Start date
- 9 Sept 2025
- Primary completion date
- Oct 2029
- Lead sponsor
- Intuitive Surgical
- Diseases
- Lung cancer
- NCT number
- NCT06923774
What you commit to
- Study type: Observational
- Planned participants: 1200
- From 9 Sept 2025 to the primary completion date, Oct 2029
- 9 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results.
Other
- Female patient that is pregnant or breast feeding as determined by standard site practices.
- Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor.
- Patient is not willing to comply with post-procedure study participation requirements.
- Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.
Who the study is looking for
- Patient is aged 18 years or older at time of consent.
- Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system.
- Patient is willing and able to give written informed consent for clinical study participation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitätsspital Zürich Coordinator of this site? Confirm its status | Zurich | Switzerland | Recruiting |
| Helios Klinikum Emil von Behring Coordinator of this site? Confirm its status | Berlin | Germany | Recruiting |
| DGD Lungenklining Hemer Coordinator of this site? Confirm its status | Hemer | Germany | Recruiting |
| Helios Dr. Horst Schmidt Kliniken Coordinator of this site? Confirm its status | Wiesbaden | Germany | Recruiting |
| CHU de Brest - Hopital de la Cavale Blanche Coordinator of this site? Confirm its status | Brest | France | Not yet recruiting |
| Hôpital Marie Lannelongue Coordinator of this site? Confirm its status | Le Plessis-Robinson | France | Recruiting |
| CHU de Rouen Coordinator of this site? Confirm its status | Rouen | France | Not yet recruiting |
| University College London Hospitals NHS Foundation Trust Coordinator of this site? Confirm its status | London | United Kingdom | Recruiting |
| Wythenshawe Hospital, Manchester University NHS Foundation Trust Coordinator of this site? Confirm its status | Manchester | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.